Fresenius Medical Care AG & Co. KGaA $FMS Stock Position Raised by Ritholtz Wealth Management

Ritholtz Wealth Management lifted its holdings in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 252.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 84,658 shares of the company’s stock after acquiring an additional 60,652 shares during the quarter. Ritholtz Wealth Management’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $1,910,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. AQR Capital Management LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 14.2% during the first quarter. AQR Capital Management LLC now owns 14,297 shares of the company’s stock valued at $356,000 after purchasing an additional 1,777 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 160.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 37,610 shares of the company’s stock valued at $1,075,000 after buying an additional 23,163 shares during the period. American Century Companies Inc. grew its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the 2nd quarter. American Century Companies Inc. now owns 29,173 shares of the company’s stock valued at $833,000 after acquiring an additional 5,127 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock valued at $146,000 after acquiring an additional 896 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Fresenius Medical Care AG & Co. KGaA by 141.8% in the second quarter. EverSource Wealth Advisors LLC now owns 2,906 shares of the company’s stock worth $83,000 after acquiring an additional 1,704 shares during the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Zacks Research cut Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research report on Wednesday, May 27th. Wall Street Zen lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Jefferies Financial Group raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research note on Friday, May 8th. Citigroup restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, April 24th. Finally, Weiss Ratings lowered shares of Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, May 7th. Four investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Strong Sell” and a consensus price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Trading Down 0.0%

Fresenius Medical Care AG & Co. KGaA stock opened at $23.25 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.20 and a quick ratio of 0.86. The company has a market capitalization of $12.56 billion, a price-to-earnings ratio of 12.23, a PEG ratio of 4.19 and a beta of 0.80. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $28.86. The company’s fifty day moving average price is $22.33 and its two-hundred day moving average price is $22.84.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The company had revenue of $5.34 billion for the quarter. On average, analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Monday, June 8th. Investors of record on Friday, May 22nd were paid a $0.8716 dividend. This represents a dividend yield of 402.0%. The ex-dividend date of this dividend was Friday, May 22nd. This is a positive change from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is 32.11%.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.